|
LYN expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.64268598723538E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.00026711544888E-13 |
| Normal-vs-Stage2 |
1.793840E-04 |
| Normal-vs-Stage3 |
4.20769996622994E-09 |
| Normal-vs-Stage4 |
3.84030000000202E-06 |
| Stage1-vs-Stage2 |
9.495200E-01 |
| Stage1-vs-Stage3 |
9.683800E-01 |
| Stage1-vs-Stage4 |
6.596400E-01 |
| Stage2-vs-Stage3 |
9.686200E-01 |
| Stage2-vs-Stage4 |
7.939400E-01 |
| Stage3-vs-Stage4 |
7.058800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.54791801177635E-15 |
| Normal-vs-AfricanAmerican |
3.677000E-03 |
| Normal-vs-Asian |
2.898400E-02 |
| Caucasian-vs-AfricanAmerican |
9.653800E-02 |
| Caucasian-vs-Asian |
3.457200E-01 |
| AfricanAmerican-vs-Asian |
1.403370E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.77635683940025E-14 |
| Normal-vs-Female |
1.02130004453471E-09 |
| Male-vs-Female |
1.245010E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.622090E-02 |
| Normal-vs-Age(41-60Yrs) |
3.06754621703931E-12 |
| Normal-vs-Age(61-80Yrs) |
2.90356627630217E-12 |
| Normal-vs-Age(81-100Yrs) |
1.350160E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.720600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.656200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.253800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.645800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.616800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.494800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.952250E-04 |
| Normal-vs-Grade 2 |
2.7254865031523E-12 |
| Normal-vs-Grade 3 |
1.17470033700329E-10 |
| Normal-vs-Grade 4 |
1.3063999999563E-06 |
| Grade 1-vs-Grade 2 |
9.672600E-01 |
| Grade 1-vs-Grade 3 |
8.117000E-01 |
| Grade 1-vs-Grade 4 |
5.322800E-01 |
| Grade 2-vs-Grade 3 |
5.656200E-01 |
| Grade 2-vs-Grade 4 |
3.010000E-01 |
| Grade 3-vs-Grade 4 |
1.867380E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.81380466202086E-11 |
| Normal-vs-ccB subtype |
5.18363130197486E-13 |
| ccA subtype-vs-ccB subtype |
5.242300E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.05770947556039E-12 |
| Normal-vs-N1 |
1.100100E-02 |
| N0-vs-N1 |
1.202640E-01 |
|
|
